Kstation

LAENNEC Inj (2mL × 10 / 50 Vials)

Name: LAENNEC Inj (2mL × 10 / 50 Vials)
Rating: 5.00 (2 reviews)

$97.00

Specification 2mL x 10 Vials 2mL x 50 Vials

Quantity

Formulation

Key ingredients

01 Human Placenta Extract112 mg / 2 mLCellular revitalization, hepatic support

2mL × 10 or 50 per Box

Laennec inj.

Human Placenta Hydrolysate Injection

Human placenta hydrolysate injection, licensed in Korea as a prescription medicine for the improvement of liver function in chronic liver disease.

Packaging Update: Ampoule to Vial

The manufacturer is changing LAENNEC from glass ampoules to vials (new packaging released by the manufacturer in August 2026). Until existing ampoule stock is used up, your order may ship in either format, and a single order may include both.

According to the manufacturer, only the container has changed. The ingredient, 2mL volume per unit, and approved indications are the same for both formats.

Why KSTATION

✅

100% Authentic

Genuine Korean supply

🛃

97% Clearance

Proven customs success rate

❄️

Cold-Chain

Temperature-controlled shipping

Product Overview

LAENNEC Product Package Image

Professional Grade

Licensed Prescription Injection

LAENNEC inj contains 112mg of water-soluble Human Placenta Hydrolysate per 2mL ampoule, a hydrolysate containing amino acids, peptides and other placenta-derived components.

Licensed indication: improvement of liver function in chronic liver disease

Active Ingredients & Composition

Human Placenta Hydrolysate: 112mg per 2mL Water-soluble extract containing a rich complex of bioactive compounds including growth factors, peptides, amino acids, vitamins, and minerals derived from human placenta.
Growth Factors: Natural Complex Protein components of the hydrolysate.
Amino Acids & Peptides: Complete Profile Building blocks for protein synthesis and cellular metabolism.
Vitamins & Minerals: Essential Complex Cofactors and nutrients that support enzymatic processes and overall cellular health and vitality.

Ingredient Composition Infographic

Licensed Indication

The Korean licence lists one indication: improvement of liver function in chronic liver disease. KSTATION does not describe other uses.

Therapeutic Applications

The only indication on the Korean licence is the improvement of liver function in chronic liver disease. Use is determined by the treating physician.

Administration Protocol

Standard Adult Dosage

Standard dose: 2mL once daily
Intensive treatment: 2mL administered 2-3 times daily based on specific condition and medical advice

Administration Methods

• Subcutaneous injection
• Intramuscular injection

Recommended Injection Points for Professional Use

Product Specifications

Specification	Value	Details
Package Contents	10 / 50 Vials	Each ampoule contains 2mL of solution
Active Ingredient	112mg per 2mL	Human Placenta Hydrolysate
Storage Temperature	1-30°C	Room temperature storage
Container Type	Glass Ampoule or Vial	Transitioning to vials; either may ship
Administration Route	Injectable	SC or IM (per Korean licence)

2mL

Per Ampoule

10 / 50

Total Ampoules

112mg

Active Content

Safety Information & Precautions

Important Safety Information

Professional administration recommended. Carefully review patient history and contraindications before use.

Do not administer to patients with a predisposition to allergies without professional consultation
Use caution when injecting to avoid nerves and blood vessels
If a rash or other allergic symptoms occur, discontinue use immediately
Risk of transmitting infectious agents, although highly minimized by sterilization and screening, cannot be entirely eliminated

Storage Guidelines

Store in an opaque, sealed container at room temperature (1-30°C). Protect from direct sunlight and extreme temperatures. Check expiration date before use.

Professional Use Only

This product is intended for use by qualified healthcare professionals only. Proper training in injection techniques and emergency response procedures is required.

Storage and Safety Precautions Infographic

Quality Assurance & Certifications

JBP

Manufacturer

Japan Bio Products Co., Ltd.

GMP

Good Manufacturing Practice

Pharmaceutical grade production standards

Sterile

Sterilization Process

Advanced sterilization and screening protocols

Tested

Quality Control

Comprehensive safety and efficacy testing

Regulatory Compliance

LAENNEC inj is manufactured under strict pharmaceutical standards and has been approved for improving liver function in chronic hepatic disease. The product undergoes rigorous quality control testing to ensure safety and efficacy.

Source & Processing

The placenta extract is carefully sourced and processed to ensure safety and efficacy. Advanced sterilization and screening protocols minimize the risk of infectious agents while preserving the biological activity of the active compounds.

Professional Guidelines

Healthcare Provider Information

This product is intended for use by qualified healthcare professionals only. Proper assessment of patient suitability, injection technique training, and emergency response preparation are essential before administration.

Patient Selection Criteria

Licensed indication: Adults with chronic liver disease, for the improvement of liver function.
Contraindications: Patients with known allergies to placental extracts or immunocompromised individuals should be evaluated carefully.

Monitoring & Follow-up

Regular monitoring of treatment response and potential adverse reactions is recommended. Dosage and frequency adjustments should be made based on individual patient response and therapeutic goals.

Professional Administration Guidelines Chart

Treatment Outcomes

Outcomes are assessed by the treating physician against the licensed indication. KSTATION does not state treatment timelines or results.

Technical Documentation

pH 6.8-7.2

Solution pH Range

2.0mL

Volume per Ampoule

Clear

Solution Appearance

Sterile

Manufacturing Standard

Composition Analysis

The hydrolysate contains a comprehensive range of bioactive substances including growth factors, cytokines, amino acids (glycine, alanine, leucine, etc.), vitamins (B-complex, vitamin C), and essential minerals present in the hydrolysate.

Stability & Shelf Life

When stored properly in sealed ampoules at room temperature (1-30°C), LAENNEC inj maintains its potency and sterility throughout its shelf life. Protect from direct sunlight and avoid freezing.

Product Packaging and Labeling Specifications

Frequently Asked Questions

Going by its Korean licence, LAENNEC is given by subcutaneous or intramuscular injection. The licence does not list intravenous or intradermal use.

Dose and frequency follow the licence and the treating physician. KSTATION does not give dosing guidance.

Patients with known allergies to placental extracts should avoid use. Those with compromised immune systems or autoimmune conditions should be evaluated carefully. Always consult with a qualified healthcare provider before starting treatment.

Store in opaque, sealed containers at room temperature between 1-30°C. Protect from direct sunlight and extreme temperatures. Do not freeze. Check expiration dates before use and dispose of any damaged ampoules.

Most patients experience minimal discomfort during injection. Initial improvements may be noticed within 1-2 weeks, with more significant results typically seen after 4-6 weeks of treatment. Some patients may experience mild injection site reactions, which usually resolve quickly.

Additional Support

For detailed technical information, administration guidelines, or specific clinical questions, healthcare providers should consult the complete prescribing information or contact the manufacturer directly.

Related Treatment Options

Combination Therapy Considerations

Any combination with other treatments is a decision for the treating physician.

Treatment Optimization

For best results, maintain a healthy lifestyle, adequate hydration, and follow all post-treatment care instructions provided by your healthcare provider. Regular follow-up appointments help ensure optimal treatment outcomes.